In their classification system, Tervaert et al. 1 divide diabetic nephropathy into four classes based on the presence of what they consider to be increasingly serious glomerular lesions ().The ...

The global IgA nephropathy disease treatment market is poised for substantial growth, with projections indicating a robust CAGR of 20.8% during the forecast period from 2022 to 2028. This growth is ...

The global burden of diabetic nephropathy increased from 1990 to 2021, and is projected to continue increasing to 2050, ...

Balkan endemic nephropathy (BEN) is a chronic tubulointerstitial disease described only in some rural parts of southeastern Europe. One of its most peculiar characteristics is a strong association ...

Immunoglobulin A (IgA) nephropathy, also called Berger’s disease, is an autoimmune disease that affects your kidneys. IgA is an antibody. Antibodies are proteins made by your immune system.

Chronic kidney disease (CKD) has diverse etiologies and complex pathogenesis, and is prone to recurrent episodes and prolonged illness. In recent years, the prevalence of CKD has been increasing year ...

MONDAY, March 17, 2025 (HealthDay News) -- The global burden of diabetic nephropathy increased from 1990 to 2021, and is ...

Burden is projected to continue increasing through 2050, and is related to sociodemographic index. (HealthDay News) — The global burden of diabetic nephropathy increased from 1990 to 2021, and ...

The following is a summary of “Bucillamine-induced membranous nephropathy versus primary membranous nephropathy: comparing ...

This is the third indication for Fabhalta after Novartis won FDA approval of the small molecule in paroxysmal nocturnal ...

Diabetic nephropathy remains a major complication of diabetes and a leading cause of end-stage renal disease worldwide. Despite advances in diabetes management, no current treatments effectively ...